HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma. |
| |
Authors: | Siong-Seng Liau Edward Whang |
| |
Affiliation: | Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. |
| |
Abstract: | |
| |
Keywords: | |
|
|